Meso Scale Discovery develops and provides multiplex assay technology and products that enable sensitive and accurate analysis in various applications, including clinical immunology and toxicology.

Meso Scale Discovery

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

SSL by Default

Google Tag Manager

HSTS

Google Analytics

Content Delivery Network

Amazon

Associate General Counsel, Alliance Management

Adam Fine

Associate General Counsel- IP

Karina Marciani

Vice President, Sales Europe

Barry Ewen

VP, Instrument Development

Manish Kochar

Vice President, Sales and Distribution

Tom DesRoches

Sales and Support

Alain Careau

Director III, Engineering

Alex Ghesquiere

Arnaud Verlinde

Director I, Environmental Health and Safety

Brian Gass

Regional Director of Sales, Northeast

Brian Lottridge

Oskar Austegard

Director of Software Development

James Brown

Vice President

Private Washington DC Metro Area Companies (Top 10K)

Southern US Companies With More Than $10M in Revenue (Top 10K)

Maryland Companies (Top 10K)

Manufacturing Companies With More Than $100M in Revenue (Top 10K)

Meso Scale Diagnostics manufactures assays and instruments for measurements of molecules in biological samples. Their services include assay development, custom conjugation, and prototype printing services. They sell assays, plates, reagents, assay kits, assay development tools, and instrument products.

Rockville

Maryland

United States

North America

Meso Scale Diagnostics

Alexandra W. on LinkedIn: Join us at the upcoming Meso Scale Diagnostics Job Fair on May 7th at the…

Multiplex Assay Market is Set to Reach $7.7 Billion By 2032 | Registering A CAGR of 7.8%

Cancer Biomarkers Market to Achieve $50.47 Bn by 2030, Showcasing a Compound Annual Growth Rate of 17.30%

Clinical Biomarkers Market Size to Reach USD 63.04 Billion in 2032 | Emergen Research

Meso Scale Diagnostics releases antibody tests used in COVID-19 clinical trials

Meso Scale Diagnostics Receives First FDA Clearance for IVD Assay

Panels for detecting antibodies to various pathogens including SARS-CoV-2 and its variants, using a library of antigens.

Aliquots of human serum with antibodies to pathogens like SARS-CoV-2 for laboratory performance assessment.

Assays for ultra-sensitive detection of viral antigens such as SARS-CoV-2 Spike and Nucleocapsid.

Antibody sets for developing assays to detect viral antigens, including SARS-CoV-2 Spike and Nucleocapsid.

Panels of biomarkers relevant to diseases like COVID-19, available for humans and non-human primates.

Kits for quantitating multiple analytes simultaneously in a sample, available in various formats.

France

Europe

South Korea

Asia

Germany

Taiwan

jQuery

.NET 4.5

ClearSlide

F5 NGINX

Office 365

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 23, 2024 8:26 PM	4385fa15
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 23, 2024 8:26 PM	603957e0
crunchbase trigger	general	Dec 4, 2024 8:54 AM	435e8443
crunchbase profile	general	Dec 4, 2024 2:54 PM	8354ce0b
li profile	general
translate crunchbase fundingrounds	general	Dec 4, 2024 3:26 PM	72690659
peers	general	Oct 23, 2024 8:26 PM	d5440bd9
news basic	general	Oct 23, 2024 8:26 PM	62827301
bundesanzeiger	filings
financials download nd	financials
private financials	financials

MESO

COM:MESOSCALE

Meso Scale Discovery